ICOS expression on CD8 T cells responding to PD-1 blockade has previously been shown [13], while work by Chow et al. demonstrated that CXCR3 expression is important for αPD-1 efficacy in a mouse tumour model [30]. The gene discussed is CXCR3; the disease is neoplasm.